AN2 Therapeutics, Inc. (ANTX) Institutional Ownership

Ownership Summary

AN2 Therapeutics, Inc. (NASDAQ:ANTX) currently has 37 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• Institutional ownership in AN2 Therapeutics edged down to 28.7% in December 2025, compared to 32.1% in September 2025.
• In percentage terms, this reflects as a holdings change of -10.38% quarter on quarter, and a decrease of 2.63% year over year.
• Of these 37 institutional investors, 13 increased their holdings in AN2 Therapeutics, while 9 of them reduced positions, and 15 investors maintained their exposure.
• The total number of shares held by institutions in AN2 Therapeutics decreased to 8.66Mn as of December 2025, a net change of down by 1.00Mn shares quarter on quarter, and down 5.86Mn shares year over year.
• Almitas Capital LLC's holding of 1.48Mn shares as of December 31, 2025 makes it the primary institutional investor in AN2 Therapeutics, owning 4.90% of the stock.
• Among the most significant buyers of AN2 Therapeutics during December 2025 were Woodline Partners LP (145.97K), MILLENNIUM MANAGEMENT LLC (95.68K), CITADEL ADVISORS LLC (92.52K), Stonepine Capital Management, LLC (63.76K), MORGAN STANLEY (39.00K).
• Leading sellers of AN2 Therapeutics stock in December 2025 included Almitas Capital LLC (1.38Mn), RENAISSANCE TECHNOLOGIES LLC (47.00K), TWO SIGMA INVESTMENTS, LP (44.82K), LANDSCAPE CAPITAL MANAGEMENT, L.L.C. (24.70K), TWO SIGMA ADVISERS, LP (3.00K).
• The top 10 institutional holders of AN2 Therapeutics for the quarter ending December 2025 included Almitas Capital LLC (1.48Mn), VANGUARD GROUP INC (1.08Mn), PFIZER INC (715.29K), Stonepine Capital Management, LLC (627.67K), Peapod Lane Capital LLC (593.40K), BANK OF NOVA SCOTIA (459.19K), LANDSCAPE CAPITAL MANAGEMENT, L.L.C. (431.76K), BANK OF MONTREAL /CAN/ (422.08K), BANK OF AMERICA CORP /DE/ (385.31K), RENAISSANCE TECHNOLOGIES LLC (338.60K).